TCTMD31m
Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study
A higher risk of HF hospitalization was seen with dapagliflozin over empagliflozin, but one researcher urges caution.
Healio9d
Obesity medications can tackle metabolic cardiorenal disease
The effects of SGLT2 inhibitors on the kidney to prevent progression of chronic kidney disease, congestive heart failure, ...
pharmaphorum1d
Novo's next-gen diabetes drug could be best at cutting heart attacks
A year ago Eli Lilly and Boehringer Ingelheim produced results which showed their oral SGLT2 inhibitor drug Jardiance (empagliflozin ... semaglutide 0.5 mg and 1.0 mg significantly reduced ...
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of ...
New York Post29d
FDA approves Hikma’s generic version of Novo’s diabetes drug Victoza
The US Food and Drug Administration on Monday approved Hikma Pharmaceuticals’ generic version of Novo Nordisk’s diabetes drug, Victoza, clearing the way for the launch of another copy of the ...
USA Today29d
FDA approves generic in same class as Ozempic for diabetes. Could it ease shortage, price?
In a move that could eventually make weight loss drugs cheaper and easier to access, the Food and Drug Administration Monday approved a second generic in the category of medications known as GLP-1s.
Lupin gets USFDA nod for generic cystic fibrosis treatment medicine
India has the potential to increase exports of organic products up to Rs 20,000 crore in the next three years, Commerce and ...
U.S. News & World Report27d
FDA Approves Generic GLP-1 Medicine For Diabetes Treatment
THURSDAY, Dec. 26, (2024 HealthDay News) -- The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a daily injectable GLP-1 medicine for ...
FiercePharma6d
AbbVie maintains top TV ad spend spot with Skyrizi in December
and Boehringer Ingelheim and Eli Lilly’s Type 2 diabetes drug Jardiance, the last of which previously took the seventh spot on this list in October. All together, drugmakers threw $274.4 million ...
Newsweek29d
Colombia Cartel Drug Lord Deported After 25 Years in U.S. Prison
one of Colombia's legendary drug lords and a former Medellín Cartel leader, will return to his home country on Monday aboard a deportation flight from the United States after serving 25 years in ...
Benzinga.com11d
FDA Approves Weight-loss Drug Zepbound For Sleep Apnea – Will Insurance Cover This $1000-Per-Month Medication?
Those who have commercial drug insurance may qualify to pay as low as $25 for a one to three-month supply of Zepbound. For those whose commercial drug insurance does not cover Zepbound ...
pharmaphorum2d
Jardiance cleared in EU for CKD, challenging Forxiga
Boehringer Ingelheim and Eli Lilly's SGLT2 inhibitor Jardiance has been approved for chronic kidney disease in the EU - the first major market to clear the new use for the drug. Adding CKD to the ...